IMP: BOD resolution dated July 07, 2024
BOD resolution dated July 07, 2024 of Imexpharm Corporation as follows:
HOSE
> FDC: Signing an audit service agreement (11/07/2024)
> GSP: Signing an audit service agreement (11/07/2024)
> VIF: Board Decision (11/07/2024)
> HVT: Board Resolution (11/07/2024)
> GLT: Annual General Mandate 2024 (11/07/2024)
> CIA: Board Resolution (11/07/2024)
> BSC: Board Resolution (11/07/2024)
> ADC: Board Resolution (11/07/2024)
> SEB: Board Resolution (11/07/2024)
> NVL122001: Board Resolution (11/07/2024)